HomePharma

Pharma

Pharma

Karyopharm Submits FDA Application for XPOVIO Combination in Myelofibrosis

Life Sciences Times - 0
Pharma

TEZSPIRE Meets All Primary and Key Secondary Endpoints in Phase III Eosinophilic Esophagitis Trial

Life Sciences Times - 0
Pharma

FDA Approves ViiV Healthcare’s Tivicay PD for HIV Treatment in Newborns and Young Children

Life Sciences Times - 0
Pharma

Alkermes’ Alixorexton Shows Positive Phase 2 Results in Narcolepsy Type 1

Life Sciences Times - 0
Pharma

Takeda’s ORZEYFUL Approved in Japan for Narcolepsy Type 1

Life Sciences Times - 0
Pharma

Amylyx Reports Positive Phase 3 Results for Avexitide in Post-Bariatric Hypoglycemia

Life Sciences Times - 0
Pharma

ENHERTU Improves Progression-Free Survival in First-Line HER2-Mutant Lung Cancer Trial

Life Sciences Times - 0
Pharma

Karyopharm Reports $33.4 Million in Q2 Revenue, Plans August Selinexor sNDA Submission

Life Sciences Times - 0
Pharma

Cycle Pharmaceuticals Taps Forma Life Sciences for U.S. Manufacturing of CAVHANZA

Life Sciences Times - 0
Pharma

Zipalertinib-Chemotherapy Combination Meets Primary Endpoint in Phase 3 Lung Cancer Trial

Life Sciences Times - 0
Pharma

Sumitomo Pharma America Doses First Patient in Phase 1/2a Retinitis Pigmentosa Study

Life Sciences Times - 0
Pharma

Enanta Pharmaceuticals Reports $19.5 Million Q3 Loss, Advances RSV and Immunology Programs

Life Sciences Times - 0
123...99Page 1 of 99

Most Read